Sector consensus Protagonist Therapeutics, Inc.
Equities
PTGX
US74366E1029
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.40 USD | +1.71% |
|
+2.61% | -4.41% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$96.33 | +17.49% | 12 | ||||||
| CHF 677.74 | +24.13% | 23 | ||||||
| US$259.65 | +9.24% | 20 | ||||||
| US$404.19 | +19.52% | 24 | ||||||
| ₩235,751.77 | +14.17% | 22 | ||||||
| US$91 | -24.34% | 19 | ||||||
| US$545.75 | -10.66% | 12 | ||||||
| €67.85 | -5.65% | 15 | ||||||
| US$205.69 | +12.64% | 16 | ||||||
| US$230.28 | +30.26% | 15 | ||||||
| US$87.92 | +25.01% | 12 | ||||||
| US$90.63 | +18.73% | 22 | ||||||
| US$209.64 | -4.58% | 14 | ||||||
| US$70 | +1.94% | 12 | ||||||
| US$52.83 | +11.07% | 13 | ||||||
| Average | 15,922.75 | +9.26% | 17 | ||||||
| Weighted average by Cap. | 24,399.55 | +10.47% | 19 |
- Stock Market
- Equities
- PTGX Stock
- Sector Protagonist Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition